P2X7 and A2A have pro- and anti-inflammatory effects, respectively, during GVHD, whilst CD39/CD73 exerts anti-inflammatory effects through the degradation of extracellular ATP and generation of extracellular adenosine. The gene discussed is ENTPD1; the disease is graft versus host disease.